A Study of Modified mRNA Vaccines in Healthy Adults

Clinical trial NCT05397223 · COMPLETED

Trial details

NCT number: NCT05397223
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

SARS-CoV-2 Seasonal Influenza Respiratory Syncytial Virus Cytomegalovirus

Start date: 2022-05-24
Primary completion: 2026-02-27
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.